tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Financial Statements

Compare
890 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently $2.31B. The company's EPS TTM is $0.47; its P/E ratio is -22.55; Soleno Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.64. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -1.96M$ 0.00$ 0.00$ -2.19M
Operating Income$ -187.67M$ -41.38M$ -24.40M$ -31.53M$ -31.95M
EBITDA$ -173.63M$ -37.03M$ -22.10M$ -30.30M$ -22.45M
Net Income$ -175.85M$ -38.99M$ -24.07M$ -30.91M$ -24.64M
Balance Sheet
Cash & Short-Term Investments$ 291.44M$ 169.68M$ 14.60M$ 21.30M$ 49.22M
Total Assets$ 330.97M$ 180.69M$ 26.50M$ 35.55M$ 64.98M
Total Debt$ 52.83M$ 403.00K$ 155.00K$ 457.00K$ 139.00K
Net Debt$ -35.10M$ -169.28M$ -14.45M$ -20.85M$ -49.09M
Total Liabilities$ 85.86M$ 23.18M$ 16.15M$ 17.76M$ 19.43M
Stockholders' Equity$ 245.11M$ 157.51M$ 10.35M$ 17.79M$ 45.55M
Cash Flow
Free Cash Flow$ -69.31M$ -24.94M$ -20.79M$ -27.79M$ -25.23M
Operating Cash Flow$ -69.10M$ -24.94M$ -20.78M$ -27.77M$ -25.22M
Investing Cash Flow$ -225.68M$ 0.00$ -13.00K$ -22.00K$ -7.00K
Financing Cash Flow$ 213.03M$ 180.02M$ 14.09M$ -128.00K$ 53.72M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS